The Role of Lysophospholipid Metabolites LPC and LPA in the Pathogenesis of Chronic Obstructive Pulmonary Disease
Q Zhou, Y Chen, Y Liang, Y Sun - Metabolites, 2024 - mdpi.com
Chronic obstructive pulmonary disease (COPD) is a heterogeneous lung condition
characterized by persistent respiratory symptoms and airflow limitation. While there are …
characterized by persistent respiratory symptoms and airflow limitation. While there are …
Extracellular cyclophilins A and C induce dysfunction of pancreatic microendothelial cells
R Alvariño, A Alfonso, N Pérez-Fuentes… - Frontiers in …, 2022 - frontiersin.org
Extracellular cyclophilins (eCyps) A and B are chemotactic mediators in several illnesses in
which inflammation plays an important role such as diabetes and cardiovascular diseases …
which inflammation plays an important role such as diabetes and cardiovascular diseases …
KD025 shifts pulmonary endothelial cell bioenergetics and decreases baseline lung permeability
JY Lee, RP Stevens, M Kash, C Zhou… - American Journal of …, 2020 - atsjournals.org
KD025 is a ROCK2 inhibitor currently being tested in clinical trials for the treatment of fibrotic
lung diseases. The therapeutic effects of KD025 are partly due to its inhibition of profibrotic …
lung diseases. The therapeutic effects of KD025 are partly due to its inhibition of profibrotic …
Association between host genetics of sheep and the rumen microbial composition
A synergy between the rumen microbiota and the host genetics has created a symbiotic
relationship, beneficial to the host's health. In this study, the association between the host …
relationship, beneficial to the host's health. In this study, the association between the host …
Therapeutic Perspectives on ROCK Inhibition for Cerebral Cavernous Malformations
TL Montagnoli, DR de Oliveira, CAM Fraga - Kinases and Phosphatases, 2023 - mdpi.com
Cerebral cavernous malformations (CCM) are developmental venous dysplasias which
present as abnormally dilated blood vessels occurring mainly in the brain. Alterations in …
present as abnormally dilated blood vessels occurring mainly in the brain. Alterations in …
Monitoring Leukocyte Migration During AtherosclerosisIn Vivo
K Matoba - Atherosclerosis: Methods and Protocols, 2022 - Springer
Transendothelial leukocyte migration is an early event in the progression of vascular
inflammation, the underlying molecular mechanism of atherosclerosis. Inflammatory …
inflammation, the underlying molecular mechanism of atherosclerosis. Inflammatory …
Lysophosphatidic acid species are associated with exacerbation in chronic obstructive pulmonary disease
Q Li, W Wong, A Birnberg, A Chakrabarti, X Yang… - BMC Pulmonary …, 2021 - Springer
Background Chronic obstructive pulmonary disease (COPD) exacerbations are
heterogenous and profoundly impact the disease trajectory. Bioactive lipid lysophosphatidic …
heterogenous and profoundly impact the disease trajectory. Bioactive lipid lysophosphatidic …
Circ-ABCA1 promotes oxidized low-density lipoprotein-induced inflammation and phenotypic switch in vascular smooth muscle cells
F Yu, JW Liu, X Wei - Clinics, 2024 - SciELO Brasil
Objectives Atherosclerosis (AS) is a chronic inflammatory disease of the arterial wall, in
which Human Vascular Smooth Muscle Cells (HVSMCs) are involved. Nevertheless, the …
which Human Vascular Smooth Muscle Cells (HVSMCs) are involved. Nevertheless, the …
Apremilast exerts protective effects on stroke outcomes and blood–brain barrier (BBB) dysfunction through regulating Rho‐associated protein kinase 2 expression
M Wang, X Meng, Z Cheng - Brain and Behavior, 2022 - Wiley Online Library
Aims Stroke is a devastating event and a huge public health concern worldwide. Apremilast
(APR) is a selective inhibitor of phosphodiesterase‐4 involved in various neurological …
(APR) is a selective inhibitor of phosphodiesterase‐4 involved in various neurological …
A review of the neuroprotective effects of andrographolide in Alzheimer's disease
Alzheimer's disease, characterized by amyloid beta peptides and neurofibrillary tangles, is
the most prevalent cause of dementia. Nowadays, some novel medicines being developed …
the most prevalent cause of dementia. Nowadays, some novel medicines being developed …